Concomitantly, previous studies have shown a progressive upregulation of p62 in obese patients with steatosis and NASH in comparison to subjects with a normal liver, thereby suggesting a downregulation of autophagy in obese patients with hepatic steatosis and NASH [136,138]. Here, SQSTM1 is linked to metabolic dysfunction-associated steatohepatitis.